A new study was conducted using data from nine clinical trials involving more than 100,000 people who were randomly assigned to either take an aspirin every day or a placebo, for approximately six years. The results were published in the...
Warning: Pradaxa Linked to Increased Risk of Heart Attack
Boehringer Ingelheim’s Pradaxa is a new blood clot preventer, which is an alternative to half a century old warfarin. Pradaxa, chemically known as dabigatran, has been approved in the United States in October 2010 for stroke prevention in...
Johnson & Johnson Risperdal Trial; $1 Billion Claim
Earlier this week, the lawsuit involving Johnson & Johnson’s antipsychotic drug, Risperdal, got underway in Austin, Texas, and has been described by lawyers as the biggest lawsuit in Texas since the tobacco litigation in the 1990s. The...